Clinical Trials in Philadelphia

Showing 18681-18700 of 20,904 trials

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

NCT00017082

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.

Colorectal Cancer

Prologue Research InternationalStarted Apr 2001

Washington D.C., District of Columbia, United States • Boca Raton, Florida, United States • Louisville, Kentucky, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

NCT00016198

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of combining fluorouracil and leucovorin with or without oxaliplatin in treating patients who have recurrent metastatic colorectal cancer.

Colorectal Cancer

Prologue Research InternationalStarted May 2001

Tucson, Arizona, United States • Pine Bluff, Arkansas, United States • Covina, California, United States +71 more locations

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Find Trials by Condition in Philadelphia

Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

EMD 121974 in Treating Patients With Progressive or Recurrent Glioma

Elemental Formula Hypoallergenicity

Decitabine in Treating Patients With Myelodysplastic Syndrome

Interferon Alfa in Treating Patients With Advanced Kidney Cancer

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

Biodistribution and Dosimetry Evaluation of [124I]FIAU

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

A Study to Assess AFM13 in Patients With Hodgkin Lymphoma